MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)

Celularity Inc (CELU)

Celularity Inc (CELU)

||
||

Cash Flow Overview

Change in Cash
-$5,895K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Depreciation and amortization
    • Share-based compensation expense
    • Net income (loss)
    • Others
Negative Cash Flow Breakdown
    • Repayments of short-term debt - ...
    • Accrued expenses and other liabi...
    • Accounts payable
    • Others
Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Proceeds from pipe offering, net of offering costs
-
-
0
0
Transaction costs related to the issuance of promissory notes with warrants
-
40
-
-
Tax withholding on vesting of restricted stock units
-
-
-
0
Proceeds from issuance of promissory notes with warrants
-
10,000
-
-
Issuance of common stock to dragasac as consideration for inducement agreement
0
0
-1,425
0
Capital expenditures
-
0
0
0
Proceeds from the sale of common stock and warrants in july 2025 pipe
-
0
2,000
-
Rebound asset acquisition
-
0
-
-
Proceeds from related party note with ktl warrant
-
0
6,812
-
Proceeds from sanuwave convertible note receivable
-
0
0
0
Proceeds from the exercise of stock options
-
0
108
-
Proceeds from merchant cash receivable
-
-
-
891
Net cash provided by investing activities
-
0
0
0
Cash proceeds from merchant cash advance
-
1,000
2,286
-
Repayment of merchant cash advance
-
-
-
221
Proceeds from issuance of preferred stock with warrants in pipe offering
-
2,000
-
-
Issuance of warrants for services
-
-
471
317
Issuance of common stock due to strategic advisory agreement
-
108
-
-
Proceeds from warrants and short-term debt - related parties
-
0
0
0
Repayments of other short-term debt - related party (r. hariri)
0
1,519
1,069
-
Repayments of short-term debt - related parties
-
-
-
35
Transaction costs from issuing of preferred stock with warrants in pipe offering
-
210
-
-
Loss on issuance of convertible note with warrants
-
0
-2,335
-
Proceeds from issuance of short-term debt - unaffiliated
-
0
0
0
Proceeds received from exercise of warrants pursuant to dragasac inducement agreement
-
-
2,460
-
Proceeds from the exercise of warrants by dragasac
-
2,460
-
-
Tax withholding on vesting of restricted stock units
0
3
78
14
Issuance of warrants to preferred stockholders in consideration of forbearance agreement
-
49
-
-
Repayment of short-term debt - unaffiliated
-
0
0
0
Repayments of short-term debt - unaffiliated
7,042
8
113
-
Gain on forgiveness of interest
-
0
991
-
Proceeds from the sale of common stock in pipe offering
-
-
-
1,010
Repayment of related party notes
-
0
5,900
-
Payment of sepa commitment fee
300
0
0
0
Net cash (used in) provided by financing activities
-7,342
11,220
3,478
1,631
Issuance of common stock to palantir as consideration for settlement agreement
-
0
0
0
Change in fair value of derivative liability
-
65
-
-
Issuance of common stock to yorkville for debt extension and sepa commitment fee
-
0
0
0
Inventory reserve for obsolescence
-
102
-
-
Change in fair value of contingent stock consideration
-
0
-
-
Share-based compensation expense
-
3,252
2,041
2,448
Provision for inventory obsolescence
-
-
-
86
Reduction in inventory reserve for obsolescence
-
-
40
-
Impairment of preferred stock investment
-
2,890
-
-
Provision for inventory obsolescence
0
-
-
-
Other, net
-
0
0
0
Issuance of common stock as compensation expense for consulting services
-
-
0
108
Issuance of common stock for consulting expense
-
705
-
-
Loss on issuance of common stock to yorkville in connection with the side letter
0
0
0
233
Accrued r&d software
-
0
0
0
Loss on extinguishment of debt
0
0
-620
0
Depreciation and amortization
1,597
1,803
1,824
3,668
Non cash lease expense
20
23
26
29
Gain on amortization of licensing obligation
-
1,911
-
-
Provision for credit losses
200
1,504
-98
8
Change in fair value of warrant liabilities
87
-1,980
4,264
1,276
Issuance of warrants due to strategic advisory agreement
256
1,259
-
-
Loss on issuance of common stock in connection with the settlement of debt
300
1
0
21
Share-based compensation expense
1,243
-
-
-
Director fees paid with rsus
128
264
-
-
Change in fair value of debt
166
-102
824
1,075
Non cash interest expense
166
166
967
1,331
Accounts receivable
328
-548
-4,545
-3,808
Inventory
-215
-1,725
-2,307
-3,664
Prepaid expenses and other assets
-251
-261
348
204
Accounts payable
-1,322
1,835
187
1,087
Accrued expenses and other liabilities
-1,675
3,695
822
6,226
Lease liabilities
77
92
89
86
Deferred income tax liabilities
-
3
-
-
Deferred revenue
-808
-294
-914
92
Net income (loss)
874
-24,362
-23,076
-24,524
Amortization of licensing obligation
-
-
51
-
Inventory impairment
-
4,335
-
-
Net cash provided by (used in) operating activities
1,447
-5,103
-4,159
-999
Net increase (decrease) in cash, cash equivalents and restricted cash
-
6,117
-
-
Net decrease in cash, cash equivalents and restricted cash
-5,895
6,117
-681
632
Cash, cash equivalents and restricted cash at beginning of period
16,372
10,255
10,977
-
Cash, cash equivalents and restricted cash at end of period
10,477
16,372
10,255
-
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

CELU Cash Flow Sankey DiagramSankey diagram visualizing CELU cash flow for the periodDepreciation andamortization$1,597K (-12.92%↓ Y/Y)Share-based compensationexpense$1,243K Net income (loss)$874K (104.42%↑ Y/Y)Loss on issuance ofcommon stock in...$300K (488.24%↑ Y/Y)Issuance of warrants dueto strategic...$256K Prepaid expenses andother assets-$251K (0.00%↑ Y/Y)Inventory-$215K (91.57%↑ Y/Y)Provision for creditlosses$200K (427.87%↑ Y/Y)Non cash interestexpense$166K (-93.23%↓ Y/Y)Change in fair value ofdebt$166K (1283.33%↑ Y/Y)Director fees paid withrsus$128K Change in fair value ofwarrant liabilities$87K (135.95%↑ Y/Y)Lease liabilities$77K (-7.23%↓ Y/Y)Non cash leaseexpense$20K (-37.50%↓ Y/Y)Net cash provided by(used in) operating...$1,447K (148.35%↑ Y/Y)Canceled cashflow$4,133K Net decrease incash, cash...-$5,895K (-775.93%↓ Y/Y)Canceled cashflow$1,447K Accrued expenses andother liabilities-$1,675K (-161.83%↓ Y/Y)Accounts payable-$1,322K (-7876.47%↓ Y/Y)Deferred revenue-$808K (-3332.00%↓ Y/Y)Accounts receivable$328K (-75.70%↓ Y/Y)Net cash (used in)provided by financing...-$7,342K (-416.47%↓ Y/Y)Repayments of short-termdebt - unaffiliated$7,042K Payment of sepacommitment fee$300K